Latest filing published 05 Oct 2026 for Medexus Pharmaceuticals Inc.. Read the official filing
Medexus Pharmaceuticals Inc. discloses dealings in Medexus Pharmaceuticals Inc. to SEDI. In total, 127 filings cover trades dated from 1 May 2026 to 25 September 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 5 October 2026, reports a transaction in Medexus Pharmaceuticals Inc. The median gap between a trade and its publication by SEDI is 19 days. Until a filing is published, the market cannot know about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 127 declarations